RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CINGARLINI S
Collezione AOU San Luigi di Orbassano

Items : 5

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Modica R; Andreasi V; Spada F; Severi S; Bracigliano A; Ambrosio MR; Zanata I; Puliafito I; Lamberti G; Cingarlini S; Rocca PA; Pignata SA; Rinzivillo M; Persano I; Versari A; Bongiovanni A; Lastoria S; Maccauro M; Seregni E; Di Maio M; Porcu L; Giacomelli L; Ricci C; Corti F; Perfetti V; Cirillo F; Grimaldi F; Cives M; Bajetta E; et alii...

Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet). in Journal of endocrinological investigation / J Endocrinol Invest. 2021 May;44(5):989-994. doi: 10.1007/s40618-020-01393-4. Epub 2020 Aug 16.

2021
AOU San Luigi di Orbassano

Panzuto F; Maccauro M; Campana D; Faggiano A; Massironi S; Pusceddu S; Spada F; Ferone D; Modica R; Grana CM; Ferolla P; Rinzivillo M; Badalamenti G; Zatelli MC; Gelsomino F; De Carlo E; Bartolomei M; Brizzi MP; Cingarlini S; Versari A; Fanciulli G; Arvat E; Merola E; Cives M; Tafuto S; Baldari S; Falconi M; Panzuto F; Maccauro M; et alii...

Clinico-pathological features, treatments and survival of malignant insulinomas: a multicenter study. in European journal of endocrinology / Eur J Endocrinol. 2020 Apr;182(4):439-446. doi: 10.1530/EJE-19-0989.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Cingarlini S; Toaiari M; Razzore P; Bianchi A; Grossrubatscher EM; Filice A; Pia A; Piovesan A; Campana D; Zatelli MC; Pusceddu S; Colao A; Faggiano A; Fazio N; Spada F; Cosaro E; Veltroni A; Landoni L; Micciolo R; Davì MV;

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. in Gastroenterology / Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.

2018
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Mazzaferro V; Buzzoni R; Delle Fave G; Giacomelli L; Milione M; Lo Russo G; Concas L; Femia D; Prinzi N; Garattini SK; Bajetta E; Tafuto S; Di Costanzo F; Torniai M; Zaniboni A; Ortolani S; Puliafito I; Panzuto F; Colao A; Brighi N; La Salvia A; Cavalcoli F; Bongiovanni A; Fazio N; Ricci S; Duro M; Davì MV; Cauchi C; Carnaghi C; et alii...

Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study. in European journal of endocrinology / Eur J Endocrinol. 2017 Apr;176(4):453-461. doi: 10.1530/EJE-16-0809.

2017
AOU San Luigi di Orbassano

Davi' MV; Cosaro E; Piacentini S; Reimondo G; Albiger N; Arnaldi G; Faggiano A; Mantovani G; Fazio N; Piovesan A; Arvat E; Grimaldi F; Canu L; Mannelli M; Ambrogio AG; Pecori Giraldi F; Martini C; Lania A; Albertelli M; Ferone D; Zatelli MC; Campana D; Colao A; Scaroni C; Terzolo M; De Marinis L; Cingarlini S; Micciolo R; Francia G; et alii...